Literature DB >> 22260081

Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.

Céline Pirat1, Amaury Farce, Nicolas Lebègue, Nicolas Renault, Christophe Furman, Régis Millet, Saïd Yous, Silvia Speca, Pascal Berthelot, Pierre Desreumaux, Philippe Chavatte.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22260081     DOI： 10.1021/jm101360s

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  39 in total

1.  Advanced inhibition of undesired human hair growth by PPARγ modulation?

Authors:  Yuval Ramot; Arianna Mastrofrancesco; Erika Herczeg-Lisztes; Tamás Bíró; Mauro Picardo; Jennifer E Kloepper; Ralf Paus
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

2.  Synthesis and cytotoxicity studies of 1-propenyl-1,3-dihydro-benzimidazol-2-one.

Authors:  Biswadip Banerji; Sumit Kumar Pramanik
Journal:  J Chem Biol       Date:  2015-04-17

3.  Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective Agonist.

Authors:  Yan Shi; Jun Li; Lawrence J Kennedy; Shiwei Tao; Andrés S Hernández; Zhi Lai; Sean Chen; Henry Wong; Juliang Zhu; Ashok Trehan; Ngiap-Kie Lim; Huiping Zhang; Bang-Chi Chen; Kenneth T Locke; Kevin M O'Malley; Litao Zhang; Rai Ajit Srivastava; Bowman Miao; Daniel S Meyers; Hossain Monshizadegan; Debra Search; Denise Grimm; Rongan Zhang; Thomas Harrity; Lori K Kunselman; Michael Cap; Jodi Muckelbauer; Chiehying Chang; Stanley R Krystek; Yi-Xin Li; Vinayak Hosagrahara; Lisa Zhang; Pathanjali Kadiyala; Carrie Xu; Michael A Blanar; Robert Zahler; Ranjan Mukherjee; Peter T W Cheng; Joseph A Tino
Journal:  ACS Med Chem Lett       Date:  2016-04-04       Impact factor: 4.345

4.  Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists.

Authors:  Alice Asteian; Anne-Laure Blayo; Yuanjun He; Marcel Koenig; Youseung Shin; Dana S Kuruvilla; Cesar A Corzo; Michael D Cameron; Li Lin; Claudia Ruiz; Susan Khan; Naresh Kumar; Scott Busby; David P Marciano; Ruben D Garcia-Ordonez; Patrick R Griffin; Theodore M Kamenecka
Journal:  ACS Med Chem Lett       Date:  2015-08-04       Impact factor: 4.345

5.  A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo.

Authors:  Davorka Messmer; Kymmy Lorrain; Karin Stebbins; Yalda Bravo; Nicholas Stock; Geraldine Cabrera; Lucia Correa; Austin Chen; Jason Jacintho; Nicholas Chiorazzi; Xiao Jie Yan; David Spaner; Peppi Prasit; Daniel Lorrain
Journal:  Mol Med       Date:  2015-06-09       Impact factor: 6.354

6.  Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).

Authors:  Wei Wang; Yibao Ma; Tianhai He; Erin Mooney; Chunqing Guo; Xiang-Yang Wang; Xianjun Fang
Journal:  Methods Mol Biol       Date:  2022

7.  Preclinical studies of a specific PPARγ modulator in the control of skin inflammation.

Authors:  Arianna Mastrofrancesco; Daniela Kovacs; Massimiliano Sarra; Emanuela Bastonini; Giorgia Cardinali; Nicaela Aspite; Emanuela Camera; Philippe Chavatte; Pierre Desreumaux; Giovanni Monteleone; Mauro Picardo
Journal:  J Invest Dermatol       Date:  2013-10-28       Impact factor: 8.551

8.  Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis.

Authors:  Silvia Speca; Christel Rousseaux; Caroline Dubuquoy; Florian Rieder; Antonella Vetuschi; Roberta Sferra; Ilaria Giusti; Benjamin Bertin; Laurent Dubuquoy; Eugenio Gaudio; Pierre Desreumaux; Giovanni Latella
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

Review 9.  Fatty acid oxidation: An emerging facet of metabolic transformation in cancer.

Authors:  Yibao Ma; Sarah M Temkin; Adam M Hawkridge; Chunqing Guo; Wei Wang; Xiang-Yang Wang; Xianjun Fang
Journal:  Cancer Lett       Date:  2018-08-10       Impact factor: 8.679

10.  PPAR Medicines and Human Disease: The ABCs of It All.

Authors:  Anthony J Apostoli; Christopher J B Nicol
Journal:  PPAR Res       Date:  2012-08-07       Impact factor: 4.964
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.